feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / India's Rare Disease Breakthrough: XP's Genetic Eye Secrets Unlocked

India's Rare Disease Breakthrough: XP's Genetic Eye Secrets Unlocked

3 Feb

Summary

  • New genetic causes of severe eye damage in XP patients identified.
  • Consanguineous marriages identified as major risk factor for XP.
  • Early diagnosis and sun protection crucial to prevent irreversible vision loss.
India's Rare Disease Breakthrough: XP's Genetic Eye Secrets Unlocked

In a significant advancement for rare disease research in India, physicians at the LVPEI have identified novel genetic factors contributing to severe eye damage in individuals with xeroderma pigmentosum (XP). This inherited disorder renders patients exceptionally sensitive to sunlight. The research, documented in the journal 'Cornea,' represents a pioneering effort within the Indian population to understand XP's ocular manifestations.

The study examined 23 XP patients, predominantly children and young adults, revealing that over a third experienced abnormal eye growths, some with cancerous potential. Dr. Sunita Chaurasia stressed the urgency of early diagnosis, genetic counseling, and comprehensive sun protection measures to avert irreversible vision loss. Severe photophobia and varying degrees of vision impairment were common among all participants.

A key finding indicated a strong correlation between XP and consanguineous marriages, pointing to this as a major contributing factor. Advanced genetic analysis pinpointed 15 disease-causing variants in the XP-C gene, with 12 being previously unreported. Furthermore, XP-E gene variants were detected for the first time in India, associated with an increased risk of severe eye disease.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Doctors at LVPEI identified new genetic causes for severe eye damage in Indian patients with XP, a condition causing extreme sun sensitivity.
Consanguineous marriages, where parents are closely related, have been identified as a major risk factor for the occurrence of XP.
Early diagnosis, genetic counseling, and rigorous sun protection are vital to prevent irreversible eye damage and potential blindness in XP patients.

Read more news on

Indiaside-arrowHealthside-arrow
•
trending

Chelsea beats West Ham 3-2

trending

Liverpool, Newcastle face injury woes

trending

WWE Royal Rumble in Riyadh

trending

Barcelona faces Elche in LaLiga

trending

Goretzka staying at Bayern Munich

trending

ICC T20 World Cup squads

trending

Gold, silver ETFs crashed

trending

Curran, Pandya T20Is stats compared

trending

Suryakumar Yadav T20I record

You may also like

Twin Sisters' Summer Secret: One Steals All the Melanin!

27 Jan • 34 reads

article image

Eye Melanoma: More Than Just Skin Deep

25 Jan • 44 reads

article image

Steroid Abuse Fuels Silent Vision Loss Crisis

21 Jan • 60 reads

article image

New Skin Cancer Therapy Halves Recurrence Risk

20 Jan • 80 reads

article image

Sun Pharma Launches Skin Cancer Drug in US

16 Jan • 92 reads

article image